netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Docetaxel found 10 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Docetaxel Malignant disease and immunosuppression - Taxanes - 08.01.05
  Apalutamide  (Erleada®) Malignant disease and immunosuppression - Anti-androgens - 08.03.04.02
  Cytotoxic Drug Cabazitaxel Malignant disease and immunosuppression - Taxanes - 08.01.05
  Darolutamide  (Nubeqa®) Malignant disease and immunosuppression - Anti-androgens - 08.03.04.02
  Erlotinib Malignant disease and immunosuppression - Erlotinib - 08.01.05
  Pertuzumab  (Perjeta®) Malignant disease and immunosuppression - Trastuzumab - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA101: Docetaxel for the treatment of hormone-refractory metastatic prostate cancer (08.01.05)
link in drug section NICE TA391: Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel (08.01.05)
link in drug section NICE TA509: Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer (08.01.05)
link in drug section NICE TA903: Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer (08.03.04.02)


 
netFormulary